Quality guidelines for oral drug candidates: dose, solubility and lipophilicity.

•Experimental properties of GSK's oral portfolio were compared with marketed drugs.•Properties were dose, solubility and the property forecast index (chromatographic Log D + aromatic ring count).•A model combining property cutoffs differentiated GSK's candidates from oral drugs.•The model provides guidance for seeking and selecting oral clinical candidates.